Cytosorbents Corp (CTSO) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cytosorbents Corporation on April 4, 2025. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol CTSO. The report addresses a specific corporate event regarding its capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate action regarding warrants and does not contain financial performance data.
Material Changes
The primary material change reported is the extension of the expiration date for the Series B Right Warrants. These warrants were issued in connection with a previously announced rights offering. The expiration date has been extended from April 10, 2025, to June 10, 2025.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the context of the warrant extension. The event is categorized under Item 8.01 (Other Events).
Key Facts for Investor Verification
- Series B Right Warrants expiration date extended to June 10, 2025.
- Original expiration date was April 10, 2025.
- Details of the rights offering and warrant terms are referenced in the press release filed as Exhibit 99.1.
- No financial results or operational metrics are disclosed in this specific filing.